BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38899953)

  • 1. Cytokine Levels in Experimental Branch Retinal Vein Occlusion Treated With Either Bevacizumab or Triamcinolone Acetonide.
    McAllister IL; Vijayasekaran S; McLenachan S; Bhikoo R; Chen FK; Zhang D; Kanagalingam E; Yu DY
    Transl Vis Sci Technol; 2024 Jun; 13(6):13. PubMed ID: 38899953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal degeneration and associated alterations in cytokine and protein in an experimental branch retinal venous occlusion model.
    McAllister IL; Vijayasekaran S; Zhang D; McLenachan S; Chen FK; Yu DY
    Exp Eye Res; 2018 Sep; 174():133-146. PubMed ID: 29803555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inner Retinal Changes in Acute Experimental BRVO Treated With Bevacizumab or Triamcinolone Acetonide.
    McAllister IL; Vijayasekaran S; Bhikoo R; Chen FK; Zhang D; Kanagalingam E; McLenachan S; Yu DY
    Transl Vis Sci Technol; 2023 Feb; 12(2):11. PubMed ID: 36753186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.
    McAllister IL; Vijayasekaran S; Chen SD; Yu DY
    Am J Ophthalmol; 2009 May; 147(5):838-46, 846.e1-2. PubMed ID: 19211093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravitreal anti-vascular endothelial growth factor treatment on the retinal gene expression in acute experimental central retinal vein occlusion.
    Drechsler F; Köferl P; Hollborn M; Wiedemann P; Bringmann A; Kohen L; Rehak M
    Ophthalmic Res; 2012; 47(3):157-62. PubMed ID: 22116547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
    Sohn HJ; Han DH; Lee DY; Nam DH
    Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal gene expression and Müller cell responses after branch retinal vein occlusion in the rat.
    Rehak M; Hollborn M; Iandiev I; Pannicke T; Karl A; Wurm A; Kohen L; Reichenbach A; Wiedemann P; Bringmann A
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2359-67. PubMed ID: 18806298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab upregulates transthyretin in experimental branch retinal vein occlusion.
    Cehofski LJ; Kruse A; Alsing AN; Nielsen JE; Pedersen S; Kirkeby S; Honoré B; Vorum H
    Mol Vis; 2018; 24():759-766. PubMed ID: 30581282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravitreal triamcinolone acetonide on retinal gene expression in a rat model of central retinal vein occlusion.
    Rehak M; Drechsler F; Köferl P; Hollborn M; Wiedemann P; Bringmann A; Kohen L
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1175-83. PubMed ID: 21487926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
    Cheng KC; Wu WC; Chen KJ
    Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).
    Fish GE
    Trans Am Ophthalmol Soc; 2008; 106():276-300. PubMed ID: 19277242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
    Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH
    Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide induced changes in the anterior segment in a pig model of branch retinal vein occlusion.
    Vijayasekaran S; McAllister IL; Morgan WH; Mendis KR; McMenamin PG; Cringle SJ; Yu DY
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):215-22. PubMed ID: 20652816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
    Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of arteriolar constriction on retinal gene expression and Müller cell responses in a rat model of branch retinal vein occlusion.
    Köferl P; Hollborn M; Rehak J; Iandiev I; Dukic-Stefanovic S; Wiedemann P; Kohen L; Bringmann A; Rehak M
    Graefes Arch Clin Exp Ophthalmol; 2014 Feb; 252(2):257-65. PubMed ID: 24292703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.
    Moon J; Kim M; Sagong M
    Eye (Lond); 2016 Aug; 30(8):1084-90. PubMed ID: 27229707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroretinograms and level of aqueous vascular endothelial growth factor in eyes with hemicentral retinal vein occlusion or branch retinal vein occlusion.
    Yasuda S; Kachi S; Ueno S; Ushida H; Piao CH; Kondo M; Terasaki H
    Jpn J Ophthalmol; 2014 May; 58(3):232-6. PubMed ID: 24668132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion.
    Ramezani A; Esfandiari H; Entezari M; Moradian S; Soheilian M; Dehsarvi B; Yaseri M
    Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1149-60. PubMed ID: 22331147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.